They found upregulation of mTOR pathway signals in FDG-avid tumours and that treatment with an mTOR inhibitor resulted in decreased FDG uptake followed by effective tumour control in both hyperglycolytic HCC cell lines and xenograft mouse models [91]. The gene discussed is MTOR; the disease is neoplasm.